4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Ethotoin.
Acenocoumarol
Ethotoin may increase the anticoagulant activities of Acenocoumarol.
Acepromazine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Acepromazine.
Advertisement
Aceprometazine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Aceprometazine.
Alfaxalone
The risk or severity of adverse effects can be increased when Ethotoin is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Ethotoin.
Advertisement
Alphaprodine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Ethotoin.
Amisulpride
The risk or severity of adverse effects can be increased when Ethotoin is combined with Amisulpride.
Advertisement
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethotoin.
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Ethotoin.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Ethotoin.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Ethotoin.
Articaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Ethotoin.
Azelastine
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Ethotoin.
Barbital
The risk or severity of adverse effects can be increased when Ethotoin is combined with Barbital.
Benoxinate
The risk or severity of adverse effects can be increased when Ethotoin is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Ethotoin is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Benzocaine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Ethotoin is combined with Benzyl alcohol.
Brexpiprazole
The risk or severity of adverse effects can be increased when Ethotoin is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Ethotoin.
Bromperidol
The risk or severity of adverse effects can be increased when Ethotoin is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Ethotoin is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Bupivacaine.
Buprenorphine
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Ethotoin.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Ethotoin.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Ethotoin.
Butamben
The risk or severity of adverse effects can be increased when Ethotoin is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Ethotoin is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ethotoin.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ethotoin.
Carbinoxamine
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Ethotoin.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Ethotoin.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Ethotoin.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Ethotoin is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Ethotoin.
Chlormethiazole
The risk or severity of adverse effects can be increased when Ethotoin is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Ethotoin is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Chloroprocaine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Ethotoin is combined with Chlorphenamine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Ethotoin.
Chlorprothixene
The risk or severity of adverse effects can be increased when Ethotoin is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Ethotoin.
Cilostazol
The serum concentration of Cilostazol can be increased when it is combined with Ethotoin.
Citalopram
The risk or severity of adverse effects can be increased when Ethotoin is combined with Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Clemastine is combined with Ethotoin.
Clidinium
The risk or severity of adverse effects can be increased when Ethotoin is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Ethotoin is combined with Clidinium.
Clobazam
The risk or severity of adverse effects can be increased when Clobazam is combined with Ethotoin.
Clomipramine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Ethotoin is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Ethotoin.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Ethotoin.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Ethotoin.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Ethotoin.
Cocaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Ethotoin.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Ethotoin.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Ethotoin.
Cyclizine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Ethotoin.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Ethotoin.
Dantrolene
The risk or severity of adverse effects can be increased when Ethotoin is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Ethotoin is combined with Dapiprazole.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Ethotoin.
Desipramine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Desloratadine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Ethotoin.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Dexmedetomidine.
Dextromoramide
The risk or severity of adverse effects can be increased when Ethotoin is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Ethotoin.
Dibucaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Cinchocaine.
Dicumarol
Ethotoin may increase the anticoagulant activities of Dicoumarol.
Difenoxin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Ethotoin.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Ethotoin is combined with Dimenhydrinate.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Ethotoin.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Ethotoin.
Doxepin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Doxepin.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.
Duloxetine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Dyclonine.
Efavirenz
The risk or severity of adverse effects can be increased when Efavirenz is combined with Ethotoin.
Enflurane
The risk or severity of adverse effects can be increased when Ethotoin is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Ethotoin.
Escitalopram
The risk or severity of adverse effects can be increased when Ethotoin is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Ethotoin.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ethotoin.
Ethanol
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Ethotoin is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Ethotoin is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Ethotoin is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Ethotoin is combined with Etomidate.
Ezogabine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Ethotoin is combined with Felbamate.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Ethotoin.
Fexofenadine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Fexofenadine.
Flibanserin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Flibanserin.
Fluindione
Ethotoin may increase the anticoagulant activities of Fluindione.
Flunarizine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Ethotoin is combined with Flunitrazepam.
Fluoxetine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Ethotoin.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ethotoin.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Ethotoin.
Fluspirilene
The risk or severity of adverse effects can be increased when Ethotoin is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ethotoin.
Fluvoxamine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Fluvoxamine.
Fosphenytoin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Ethotoin is combined with Fospropofol.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Ethotoin.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Ethotoin is combined with Gabapentin Enacarbil.
Glutethimide
The risk or severity of adverse effects can be increased when Ethotoin is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Ethotoin is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Ethotoin.
Halothane
The risk or severity of adverse effects can be increased when Ethotoin is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Ethotoin is combined with Hexobarbital.
Hydrocodone
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ethotoin.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.
Iloperidone
The risk or severity of adverse effects can be increased when Ethotoin is combined with Iloperidone.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Ethotoin.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Ethotoin.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Ethotoin.
Ketazolam
The risk or severity of adverse effects can be increased when Ethotoin is combined with Ketazolam.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Ethotoin.
Levetiracetam
The risk or severity of adverse effects can be increased when Ethotoin is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Ethotoin is combined with Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Ethotoin is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Ethotoin is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Ethotoin.
Lidocaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Lidocaine.
Lithium
The risk or severity of adverse effects can be increased when Ethotoin is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Ethotoin is combined with Lithium.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Ethotoin.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Ethotoin.
Lormetazepam
The risk or severity of adverse effects can be increased when Ethotoin is combined with Lormetazepam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Ethotoin.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Ethotoin.
Magnesium Sulfate
The therapeutic efficacy of Ethotoin can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Ethotoin can be increased when used in combination with Magnesium sulfate.
Maprotiline
The risk or severity of adverse effects can be increased when Ethotoin is combined with Maprotiline.
Meclizine
The risk or severity of adverse effects can be increased when Meclizine is combined with Ethotoin.
Mefloquine
The therapeutic efficacy of Ethotoin can be decreased when used in combination with Mefloquine.
Melatonin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Ethotoin.
Mephobarbital
The risk or severity of adverse effects can be increased when Ethotoin is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Ethotoin.
Mesoridazine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ethotoin.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Ethotoin.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Ethotoin is combined with Methadyl Acetate.
Methapyrilene
The risk or severity of adverse effects can be increased when Ethotoin is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Ethotoin is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Ethotoin.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Ethotoin.
Methotrimeprazine
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Ethotoin is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Ethotoin is combined with Methsuximide.
Metylperon
The risk or severity of adverse effects can be increased when Ethotoin is combined with Melperone.
Metyrosine
Ethotoin may increase the sedative activities of Metyrosine.
Mianserin
The therapeutic efficacy of Ethotoin can be decreased when used in combination with Mianserin.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Ethotoin.
Milnacipran
The risk or severity of adverse effects can be increased when Ethotoin is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.
Mirtazapine
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Molindone
The risk or severity of adverse effects can be increased when Ethotoin is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Ethotoin.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ethotoin.
Nefazodone
The risk or severity of adverse effects can be increased when Ethotoin is combined with Nefazodone.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Ethotoin.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Ethotoin.
Norflurane
The risk or severity of adverse effects can be increased when Ethotoin is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Ethotoin is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ethotoin.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Ethotoin.
Olopatadine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Olopatadine.
Ondansetron
The risk or severity of adverse effects can be increased when Ethotoin is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Ethotoin is combined with Opium.
Orlistat
The serum concentration of Ethotoin can be decreased when it is combined with Orlistat.
Orphenadrine
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Ethotoin.
Oxprenolol
The risk or severity of adverse effects can be increased when Ethotoin is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Ethotoin.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Ethotoin.
Paliperidone
The risk or severity of adverse effects can be increased when Paliperidone is combined with Ethotoin.
Paraldehyde
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Ethotoin.
Paroxetine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Paroxetine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Ethotoin.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Ethotoin.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.
Perazine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Ethotoin.
Phenindione
Ethotoin may increase the anticoagulant activities of Phenindione.
Phenobarbital
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Ethotoin.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Ethotoin is combined with Phenoxyethanol.
Phenprocoumon
Ethotoin may increase the anticoagulant activities of Phenprocoumon.
Phenytoin
The risk or severity of adverse effects can be increased when Phenytoin is combined with Ethotoin.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Ethotoin.
Pipamperone
The risk or severity of adverse effects can be increased when Ethotoin is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Pipotiazine.
Pirinitramide
The risk or severity of adverse effects can be increased when Ethotoin is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Ethotoin is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Ethotoin is combined with Pomalidomide.
Pramipexole
Ethotoin may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Ethotoin is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Ethotoin can be decreased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Prilocaine.
Primidone
The risk or severity of adverse effects can be increased when Ethotoin is combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Procaine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Ethotoin.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Ethotoin.
Promethazine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Promethazine.
Proparacaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Ethotoin.
Propoxyphene
The risk or severity of adverse effects can be increased when Ethotoin is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ethotoin.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Ethotoin.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Ethotoin.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Ethotoin.
Ramelteon
The risk or severity of adverse effects can be increased when Ethotoin is combined with Ramelteon.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ethotoin.
Remoxipride
The risk or severity of adverse effects can be increased when Ethotoin is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Ethotoin.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Ethotoin.
Ropinirole
Ethotoin may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Ropivacaine.
Rotigotine
Ethotoin may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Ethotoin.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Ethotoin.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Ethotoin.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Ethotoin.
Sertindole
The risk or severity of adverse effects can be increased when Ethotoin is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Ethotoin is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Ethotoin.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Ethotoin.
Sulpiride
The risk or severity of adverse effects can be increased when Ethotoin is combined with Sulpiride.
Suvorexant
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.
Tasimelteon
The risk or severity of adverse effects can be increased when Ethotoin is combined with Tasimelteon.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Ethotoin.
Tetrabenazine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Ethotoin is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.
Thalidomide
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Ethotoin is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Ethotoin is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Ethotoin is combined with Thiopental.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Ethotoin.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ethotoin.
Tiagabine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Ethotoin is combined with Tiapride.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Ethotoin.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Ethotoin.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Ethotoin.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Ethotoin.
Tranylcypromine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Ethotoin is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Ethotoin.
Triazulenone
The risk or severity of adverse effects can be increased when Ethotoin is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ethotoin.
Triflupromazine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Triflupromazine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Ethotoin.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Ethotoin.
Urethane
The risk or severity of adverse effects can be increased when Ethotoin is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Ethotoin is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Ethotoin is combined with Valproic Acid.
Venlafaxine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Venlafaxine.
Vigabatrin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Vigabatrin.
Vortioxetine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Vortioxetine.
Warfarin
Ethotoin may increase the anticoagulant activities of Warfarin.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Ethotoin.
Ziconotide
The risk or severity of adverse effects can be increased when Ethotoin is combined with Ziconotide.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Ethotoin.
Zolpidem
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Ethotoin is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Ethotoin.
Zotepine
The risk or severity of adverse effects can be increased when Ethotoin is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Ethotoin.
